Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder. Journal Articles uri icon

Overview

Published in

  • European Urology

Time

Date/time value

  • 2004

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2004.01.008

Additional Document Info

Parent Title

  • Eur Urol

Volume

  • 45

Issue

  • 4

Publisher

  • Elsevier BV